ArticleBreast cancer research and treatment2024

Treatment patterns of patients with HR+/HER2- metastatic breast cancer receiving CDK4/6 inhibitor-based regimens: a cohort study in the French nationwide healthcare database.

Stephanie H Read et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.